- ICH GCP
- EU-register voor klinische proeven
Laatste proeven
EudraCT Number: 2008-003600-55 | Sponsor Protocol Number: ALN-RSV01-106 | Start Date: | |||||||||||
Sponsor Name: Alnylam Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Antiviral Activity of Aerosolized ALN-RSV01 Plus Standard of Care in Lung Transplant Patients Infected ... | |||||||||||||
Medical condition: Lung transplant patients with Human respiratory syncytial virus (RSV) infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-005004-40 | Sponsor Protocol Number: K/602 | Start Date: | ||||||
Sponsor Name: Cassella-med | ||||||||
Full Title: Multizentrischer, randomisierter, doppelblinder, Placebo-kontrollierter Parallelgruppenvergleich zum Nachweis der Wirksamkeit und Unbedenklichkeit von Chinin bei Patienten mit Fibromyalgie | ||||||||
Medical condition: Fibromyalgie | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: DE (Completed) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2010-022941-72 | Sponsor Protocol Number: PMR-EC-1503 | Start Date: | |||||||||||
Sponsor Name: Astellas Pharma Europe Ltd. | |||||||||||||
Full Title: A MULTICENTER, TWO ARM, RANDOMIZED, OPEN LABEL CLINICAL STUDY TO COMPARE RENAL FUNCTION IN STABLE HEART TRANSPLANT RECIPIENTS RECEIVING AN ADVAGRAF® BASED IMMUNOSUPPRESSIVE REGIMEN WITH OR WITHOUT ... | |||||||||||||
Medical condition: Prophylaxis of heart transplant rejection. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Prematurely Ended) SK (Prematurely Ended) CZ (Prematurely Ended) ES (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-002465-30 | Sponsor Protocol Number: EE-01bude2014 | Start Date: | ||||||
Sponsor Name: Dip. Pediatria UOC Gastroenterologia ed Epatologia Pediatrica | ||||||||
Full Title: Spontaneous study on the efficacy and safety of an oral viscous suspension of budesonide administered to children affected by eosinophilic esophagitis. | ||||||||
Medical condition: Eosinophilic Esophagitis | ||||||||
|
||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||
Trial protocol: IT (Ongoing) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003395-39 | Sponsor Protocol Number: MRX-503 | Start Date: | |||||||||||
Sponsor Name: Mirum Pharmaceuticals Inc. | |||||||||||||
Full Title: MRX-503: An Open-label Extension Study to Evaluate the Long-term Safety and Efficacy of Maralixibat in the Treatment of Subjects with Progressive Familial Intrahepatic Cholestasis (PFIC) | |||||||||||||
Medical condition: In patients with progressive familial intrahepatic cholestasis (PFIC), impairment of the egress of bile acids from the liver leads to cholestasis, hepatocellular injury and damage, and progressive ... | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) GB (GB - no longer in EU/EEA) BE (Ongoing) PL (Ongoing) FR (Ongoing) HU (Ongoing) AT (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-022984-36 | Sponsor Protocol Number: 201051 | Start Date: | ||||||||||||||||||||||||||
Sponsor Name: Santen Oy | ||||||||||||||||||||||||||||
Full Title: A phase III, randomized, double-masked 6-month clinical study to compare the efficacy and safety of the preservative-free fixed dose combination of tafluprost 0.0015% and timolol 0.5% eye drops to ... | ||||||||||||||||||||||||||||
Medical condition: Patients diagnosed with ocular hypertension or open-angle glaucoma (primary open-angle glaucoma [POAG], capsular glaucoma or pigmentary glaucoma). | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: HU (Completed) LV (Completed) CZ (Completed) ES (Completed) PT (Completed) AT (Completed) BG (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-000278-13 | Sponsor Protocol Number: P16-07/BP052 | Start Date: | |||||||||||
Sponsor Name: BIOPROJET PHARMA | |||||||||||||
Full Title: Palatability testing in children of a new paediatric formulation of Racecadotril as oral suspension strawberry-flavored administered via an oral graduated syringe compared to the current formulatio... | |||||||||||||
Medical condition: Young healthy volunteers (7-12 years) | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-021800-72 | Sponsor Protocol Number: DB2113360 | Start Date: | |||||||||||
Sponsor Name: GlaxoSmithKline Research & Development Ltd | |||||||||||||
Full Title: DB2113360: A multicenter trial comparing the efficacy and safety of GSK573719/GW642444 with GW642444 and with tiotropium over 24 weeks in subjects with COPD | |||||||||||||
Medical condition: subjects with COPD | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) PL (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004009-22 | Sponsor Protocol Number: WVE-DMDX51-003 | Start Date: | |||||||||||
Sponsor Name: Wave Life Sciences UK Limited | |||||||||||||
Full Title: A Randomized, Double-blind, Placebo-controlled, Efficacy and Safety Study of WVE-210201 in Ambulatory Patients with Duchenne Muscular Dystrophy | |||||||||||||
Medical condition: Duchenne muscular dystrophy | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male | ||||||||||||
Trial protocol: FR (Ongoing) GB (Prematurely Ended) SE (Prematurely Ended) NL (Ongoing) BE (Prematurely Ended) PL (Prematurely Ended) CZ (Prematurely Ended) DE (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-002455-16 | Sponsor Protocol Number: LTGV550-PII-11/06 | Start Date: | |||||||||||
Sponsor Name: Laboratoires Théa | |||||||||||||
Full Title: Efficacy and safety of GV 550 in acute adenoviral keratoconjunctivitis | |||||||||||||
Medical condition: acute adenoviral keratoconjunctivitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |